Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Start-Up Spotlight: XEPTAGEN

Posted on March 10th, 2017 by in Pharma R&D

Half the battle of treating a disease is to first diagnose it in a timely manner. XEPTAGEN, based in Venice, Italy, aims to develop effective, inexpensive tests to diagnose cancer and liver disease. Continue reading “Start-Up Spotlight: XEPTAGEN” »

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »

Arctic Pharma CEO Talks Early-Stage Research

Posted on December 27th, 2016 by in Pharma R&D

One of the amazing things about doing early-stage research is that it can often take you in unexpected directions. Claudia Bøen was working as a scientist on developing a male contraceptive for Spermatech when their team found that a compound they were working with killed certain cancer cells. Continue reading “Arctic Pharma CEO Talks Early-Stage Research” »

Start-Up Spotlight: Can-Fite BioPharma

Posted on December 16th, 2016 by in Pharma R&D

“Safety first” could be the motto of drug development company Can-Fite BioPharma, based in Israel. Dr. Sari Fishman, Director of Business Development, tells us about Can-Fite’s drug candidates, Continue reading “Start-Up Spotlight: Can-Fite BioPharma” »

  1. 1
  2. 2
  3. 3
  4. 4